initi coverag market perform new ceo strategi
initi coverag anglogold ashanti market perform rate target
like improv outlook au seen close rise rel peer last
four month trade line peer
look solid execut obuasi improv mine life visibl
new ceo
macro sector updat
initi coverag under-perform still overweight south deep
initi coverag gold field under-perform rate target price
hard call like direct compani taken toward portfolio manag
key concern remain still reserv life front continu
exposur south africa
resolut strike activ measur oper progress restructur south deep
would key catalyst reconsid rate pleas see report initi anglogold gold
field newcrest gold univers
initi coverag market perform solid base look option
initi coverag newcrest market perform rate target price
ncm fit well best class thesi laid earlier year strong execut
averag outlook addit peer-lead return sinc restructur began four year
ago industry-lead asset base reserv life
howev compani issu free asset concentr declin gold product cadia
begin elev jurisdict risk wafi-golpu develop key issu
report prepar part analyst employ canadian affili bmo nesbitt burn inc
uk affili bmo capit market limit authoris regul financi servic
author uk regist research analyst finra rule
disclosur statement includ analyst certif pleas refer page
upgrad outperform detail sum-of-the-part epsilon support upsid
upgrad share outperform market perform leav price target
believ strateg acquir valu epsilon highli public market current
support breakdown valuat epsilon seven unit separ
share current sit near three-year low transact could announc within next
month valu epsilon ev/adjust ebitda could see sold whole
part
upgrad outperform market perform outlook
public outlook upgrad share outperform
transit sleep apnea compani one full interconnect throw
benefit recent acquisit new product launch good year
specif year integr matrixcar propel health one launch
mobi copd devic opportun addit oper leverag increas
estim target price
downgrad market perform headwind
follow addit anglogold ashanti gold field newcrest mine coverag
reconsid recommend among broader univers larg gold produc coverag
downgrad share yamana gold market perform
shield canadian
believ cardin energi make arguabl tough prudent decis temporarili
reduc dividend reduct strive mainten budget deal
wide differenti face canadian produc
share could pressur think decis preserv long-
term valu uncertain time
although wrong direct share price still retain outperform
rate howev lower target price lower expect
thor report signific reduct revenu ep backlog
street expect pain print dealer inventori level brought
significantli sequenti basi compani appear much better situat
retail season disappoint clear channel take longer expect
howev believ demand outdoor lifestyl experi still strong
capit strong secular trend
view despit manag optim respect synergi year
four follow svu acquisit visibl ebitda could stabil remain even
challeng expect financi model highli complic low visibl
maintain market perform-r share cut target price still
see risk valuat ebitda even current level
 day outlin acceler path
believ day provid clear registr strategi includ potenti
acceler path tmf ctcl hl
believ demonstr suffici proof concept base multipl monotherapi
studi keytruda combo studi expect similar respons rate high seen
columbia-l ctcl studi orr includ cr
seek development partner combo hl advanc
phase compani retain right drug
sale visibl continu improv reiter outperform rate
comtech report strong octob quarter better-than-expect revenu adjust ebitda
result encourag see solid momentum across two major segment order
metric remain strong newer product offer like height grow rapidli
updat guidanc also impress go forward believ comtech maintain
robust pipelin meaning opportun troposcatt forc track
maintain outperform rate share
amazon canadian tire stand one year later
alway believ amazon present challeng canadian tire point
futur
recent commiss market research survey canadian order gather addit
data consum usag amazon canada impact amazon canadian
rate share market perform result expect adj ep vs
quebec macroeconom indic remain support cautious optimist outlook
saw sssg slow vs strong
ultim expect spend quebec furnitur market remain choppi lead
modest-to-flat earn growth light believ stock reason valu
investor day focu emerg late-stag opportun
believ ioni investor day provid greater visibl numer mid-stag pipelin drug
enter pivot studi next two year
ioni expect phase program partner unpartn across broad
rang therapeut indic includ cv neurodegen cancer rare diseas
updat commerci product limit focu primarili robust line-
futur late-stag opportun drive next stage top-lin growth
believ obseva provid compel case nolasiban ivf opportun day
potenti file europ among largest ivf market
expect share reflect greater nolasiban valu commerci approach
visibl peak sale opportun expect uf phase data valid
linzagolix favor profil market leader orilissa enabl drug captur meaning
share despit third gnrh antagonist reach market
ptl remain upsid estim
nov job headlin weak temp growth improv rate all-tim
non-farm job increas novemb consensu estim
unemploy rate stabl prior month labor particip rate
annual temp growth improv sequenti temp penetr rate hit all-tim high
indic potenti improv temp usag staf stock tend outperform improv
industri activ acceler econom growth
prefer select staf exposur later-cycl secular-growth trend
defens flow trend remain intact care stapl display bullish creation breakout
sentiment gaug high yield sr loan market turn sharpli bearish januari
recent sell-off consist investor sentiment group suffer billion
outflow recent price weak trigger second leg outflow
observ dispers member return within cdn-list dividend etf investor begin
avoid dividend grower favour qualiti high dividend payer
factor analysi also consist etf screen analysi show investor
adjust post-q environ underpin invest decis qualiti debt
servic metric sinc compani good debt servic abil outperform
initi anglogold gold field newcrest gold univers
expand coverag larg gold produc initi south african
anglogold ashanti market perform gold field under-perform australian-domicil
futur catalyst interest best-in-class larg gold produc remain
outperform-r agnico eagl
movi field dream iowa corn farmer hear voic interpret
command build basebal diamond field build field despit mani
peopl dismay chicago white sarbanes-oxley come play sometim medic devic feel
way compani driven develop product frequent despit mani peopl dismay
includ physician patient investor ultim lead someth remark
lifesav happen
look year build case product cycl
sale visibl continu improv reiter
bottom line comtech report strong octob quarter better-than-expect
revenu adjust ebitda result encourag see solid momentum
across two major segment order metric remain strong newer product
offer like height grow rapidli updat guidanc also impress
go forward believ comtech maintain robust pipelin meaning
opportun troposcatt forc track maintain outperform
rate share
mostli solid result sale y/i top our/consensu estim
major segment outperform expect gross margin
miss estim bp oper margin miss
bp ep miss estim penni adjust ebitda top
estim note prior estim actual result
significantli consensu expect quarter
strong guid updat revenu guidanc higher
prior rang midpoint estim manag guid
adjust ebitda midpoint prior midpoint guid
ep guidanc rang compar previou rang
manag believ potenti exceed financi target
order momentum impress steadi stream contract win includ
contract armi product contract
fortun custom solut backlog million y/i
close peak level seen addit backlog roughli
unfund contract place togeth bring potenti revenu visibl
billion
addit opportun comtech current await result larg multi-
year rfp suppli govern new troposcatt equip believ
compani well-posit win contract could repres year
meaning revenu contribut
valuat recommend unchang target price assum
stock trade ev/ebitda multipl estim line peer
posit comtech given strong opportun
across varieti end market includ public
safeti govern commerci satellit
use invest
chang
total liabil share equiti
target price assum stock trade ev/
ebitda multipl estim
upsid case share price base
adjust ebitda million target multipl
price-to-earnings upsid case includ addit bp
revenu growth addit bp margin
expans versu base case assumpt
comparison downsid case share
price base ep million target
multipl price-to-earnings case assum bp reduct
revenu growth bp less oper margin
versu base case assumpt
usd
multipl recent contract driven strong backlog
growth compani new height platform gain
traction least million revenu contribut
expect comtech bidder major
troposcatt rfp could contribut hundr
million dollar
make product servic
two custom segment govern commerci
repres approxim half sale comtech
power amplifi command control solut satellit
earth station product next-gener system
bottom line thor report signific reduct revenu ep
backlog street expect pain print
dealer inventori level brought significantli sequenti basi
compani appear much better situat retail season
disappoint clear channel take longer expect howev
believ demand outdoor lifestyl experi still strong
capit strong secular trend
report ep includ hymer-rel
transact cost adjust ep still short estim street
consensu report
revenu billion yoy short bn estim
street consensu bn shipment declin
expect shipment also lag rest industri
steep declin shipment though need clear
retail channel build-up inventori especi retail demand
normal sustain mid-single-digit growth rate
dealer inventori yoy deceler compar growth
came lower expect sequenti channel inventori
declin high water mark set
asp grew estim driven price increas partial off-set
discount move dealer inventori mix toward higher-end product
gross margin contract owe loss leverag raw materi cost pressur
warranti expens discount off-set higher mix
manag comment expect retail stabl
line histor retail pattern wholesal shipment rate retail
align didnt provid specif year year expect
howev slash estim account longer-than-expect
ration retail channel well slower sustain rate
believ benefit rv industri
tailwind includ age popul on-going
replac cycl popular rv among
millenni acquisit erwin hymer
howev commun concern raw
materi inflat like pressur margin
well need normal dealer inventori level
could impact shipment short term
chang work capit
chang
target price repres calendar ep
estim ep estim
ep estim
demand rv industri continu remain
robust think compani could earn per share
trade multipl offer potenti upsid
economi deterior consum confid
declin believ rv demand would contract quickli
thor may find support increas
multipl would also contract situat
ep estim could declin market
appli discount multipl put downsid risk
usd
monthli rv retail sale data shift sentiment result
identifi via channel check dealer survey
thor world largest manufactur rv includ
towabl motor home
downgrad market perform headwind
bottom line follow addit anglogold ashanti gold field newcrest
mine coverag reconsid recommend among broader univers
larg gold produc coverag downgrad share yamana gold
upgrad yamana advanc commerci product cerro moro
impact new mine toward futur de-lever
yamana execut well cerro moro howev follow upgrad
govern announc argentina export tax along persist low gold
silver price copper forward sale temper yamana return free cash
flow de-lever
auy portfolio undergon step chang portfolio qualiti follow ramp-up
cerro moro howev move share yamana market perform
opportun out-performance cap risk outlin
reduc target price reflect cfp bmo metal
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
view opportun out-performance
afford ramp-up cerro moro
accompani forecast free cash flow gener
temper risk around argentinian export tax
combin persist low gold silver price
copper forward sale
auy trade npv estim bmo metal
price assumpt versu senior gold produc averag
target price base npv/sh
cfp bmo metal price assumpt
upsid scenario base weight
npv/sh cfp bmo metal price assumpt
downsid scenario base weight
npv/sh cfp bmo metal price
usd
capit spend budget continu ramp cerro
design rate strateg asset review updat
on-going explor
yamana gold senior gold produc asset
throughout america brazil argentina chile
improv rate all-tim high
bottom line non-farm job increas novemb
consensu estim unemploy rate stabl prior month
labor particip rate also unchang annual temp growth improv
sequenti temp penetr rate hit all-tim high indic potenti
improv temp usag staf stock tend outperform improv
industri activ acceler econom growth prefer select staf
exposur later-cycl secular-growth trend
 labor market increas job novemb consensu
expect increas privat employ exclud govern
agenc increas job job growth health care manufactur
transport wareh
unemploy rate remain stabl prior month
labor particip rate unchang
averag hourli earn increas annual wage inflat
stabl last month rate averag hourli wage temporari
employe increas y/i moder slightli last month rate
revis averag weekli hour work product nonsupervisori privat
industri sequenti flat
increas y/i novemb improv slightli last month y/i
increas revis unadjust basi indic actual result volum
rose y/i novemb slow slightli last month increas
increas sequenti rel histor increas octob
novemb unadjust basi indic direct trend volum
increas rel histor increas octob novemb
temp penetr rate temp percentag total workforc hit all-tim
high novemb slightli prior month revis
peak prior two cycl april novemb
continu select staf exposur staf stock tend outperform
improv industri activ acceler econom growth also
recommend outperform-r staf secular growth compon
alway caution investor data base monthli survey
notori revis
investor day focu emerg late-stag
bottom line believ ioni investor day provid greater visibl numer
mid-stag pipelin drug enter pivot studi next two year ioni expect
phase program partner unpartn across broad
rang therapeut indic includ cv neurodegen cancer rare
diseas updat commerci product limit focu primarili
robust line-up futur late-stag opportun drive next stage
top-lin growth profit
tegsedi launch work logist believ tegsedi similar launch
hurdl alnylam onpattro manag comment suggest prescript
still process includ reimburs confirm patient dose
ioni expect patient drug shortli believ consensu estim
like high given onpattro first quarter eu tegsedi could
narrow sale miss patient receiv drug germani
waylivra fate remain uncertain partner akcea commerci
infrastructur place europ anticip waylivra approv
regulatori path still fda discuss august ioni optimist
rapid resolut believ phase data could shift fc
program lica version waylivra
ttr-lrx emerg clinic plan replac tegsedi ionis/akcea next gen ttr drug
ttr-lrx expect complet phase start pivot studi
place six month behind alnylam vutrisiran ioni expect rapid phase
studi hattr-pn leverag tegsedi neuro data second phase trial also
start evalu hattr wt patient cv outcom endpoint
ioni expect cm studi head-to-head tafamidi manag believ
emerg late-stag pipelin drive futur growth therapi enter
phase see page believ ioni set stage long-term revenu
growth increas profit estim multipl opportun blockbust
drug includ apo -lrx cv diseas htt-rx huntington
rx famili al believ lica platform could gener safer potent
therapi allow access broad diseas popul major ioni pipelin
upsid street estim includ wholli own b-thal
nash ghr-lrx acromegali
believ ioniss lead candid could chang
cours multipl rare diseas includ sma hattr/
wtattr fc expect near-term focu
spinraza quarterli sale launch inotersen
volanesorsen approv data updat
total liabil share equiti
target price base dcf
free cash flow discount wacc
termin growth rate rate share
upsid scenario model strong launch inotersen
higher spinraza sale rapid refil approv
volanesorsen believ criteria would support
share price ioni pipelin asset repres
ww spinraza growth flatten volanesorsen refil
approv beyond one year criteria
estim would decreas result downsid share
price
usd
updat fda discuss volanesorsen refil
apo -lrx phase iib data inotersen
pdufa octob
biotech compani focus
develop antisens drug therapi treat varieti
sever rare diseas wholly-own subsidiari
akcea focus develop ioni lipid franchis
stanley crook found ioni januari
headquart carlsbad california
bottom line rate share market perform result
expect adj ep vs forecast sssg vs forecast
quebec macroeconom indic remain support cautious optimist outlook
saw sssg slow vs strong ultim
expect spend quebec furnitur market remain choppi lead modest-
to-flat earn growth light believ stock reason
report adjust ep estim note
end oct follow fiscal ye chang decemb januari
impact y/i compar last year end septemb
oper result forecast sale million
estim million sssg essenti line adjust ebitda
million million forecast due lower-than-expect
sale sg percent sale higher expect sale vs
forecast gross margin slightli better forecast vs
forecast ebitda margin estim bp
sssg line bmo econom forecast favour macroeconom
indic quebec unemploy vs
growth vs condit remain favour impact rise
interest rate begin weigh discretionari spend reflect sssg
slow
build-out e-commerc capabl standard system across
banner continu continu build-out e-commerc platform brault
 martineau economax complet remain phase well websit
restructur banner infrastructur spend
continu year total cost estim million million incur
estim decreas modestli target price unchang
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
rate share market perform
cautious optimist furnitur retail market
quebec light modest hous growth
improv unemploy notwithstand
prototyp store renov cost like weigh
sg medium term believ achiev
materi earn growth challeng
adj sg sale
chang non-cash wc
cfo w/c
free dividend
dividend
dividend adj ni
total liabil share equiti
note chang fiscal ye januari result result period
target price base ev/ebitda
share current trade ev/ebitda
target valuat multipl line canadian
publicli trade peer slightli lower furnitur
 applianc manufactur line histor
averag past four year
posit view stock could lead forecast
ebitda growth target multipl
ev/ebitda impli share price
repres potenti upsid current share price
bear case forecast ebitda declin
target multipl ev/ebitda impli
share price repres potenti downsid
current share price
cad
macroeconom growth quebec construct new
format store across entir network continu
build-out e-commerc capabl drive sale
hold compani furnitur electron
household applianc retail oper almost
store brault et martineau ameubl
tanguay affili montreal quebec citi laval ste-foy
du-loup chicoutimi gatineau
bottom line view despit manag optim respect
synergi year four follow svu acquisit visibl ebitda
could stabil remain even challeng expect financi
model highli complic low visibl maintain market perform-r
share cut target price still see risk valuat
ebitda even current level
adjust ebitda guidanc lower definit chang key element
result updat guidanc respect svu acquisit
close final week quarter flash note
recap page insid summari
manag continu optim respect synergi year
visibl ebitda could stabil remain even challeng
expect financi model highli complic exampl trend alreadi
weaker expect svu organ wholesal sale due gener
soft custom uncertainti around transact debt level high
calcul debt/ebitda svu alreadi process integr two
acquisit unifi grocer ag florida pend retail divestitur
could take time prove challeng sell still guidanc expect proce
note signific post-tax pension svu still challeng
margin mix-shift pressur core gm yoy lower-
margin wfm continu outpac peer term sale
model ebtida yoy despit synergi cut tp lower
tp shift valuat maintain ev/ebitda
multipl though acknowledg still risk lower multipl ebitda
forecast ebitda yoy potenti loss retail
ebitda lap extra week estim continu gross margin
pressur uncertainti surround strand retail cost may take
time mitig off-set estim synergi realiz
view despit manag optim
respect synergi year four follow svu
acquisit visibl ebitda could stabil
remain even challeng expect
financi model highli complic low
visibl maintain market perform-r
good sold
tax ebit
histor two-year forward ev/ebitda multipl
rang high low averag
target price base ev/ebitda
investor gain greater confid manag
integr plan abil stabil margin drive
expans valuat near
manag struggl integr svu and/or on-going
margin pressur lead deterior visibl
core busi lead multipl compress
usd
cpi data monthli iri data addit news
amazon surround whole food market
distributor natur organ
specialti foods/non-food product canada
oper distribut center
natur retail headquart
initi coverag under-perform still
bottom line initi coverag gold field under-perform rate
target price hard call like direct compani taken
toward portfolio manag key concern remain still
reserv life front continu exposur south africa resolut
strike activ measur oper progress restructur south deep
would key catalyst reconsid rate pleas see report initi
anglogold gold field newcrest gold univers
stewardship ceo nick holland gold field embark upon well-tim
corpor restructur plan prior onset declin gold price
look back melbourn mine club present juli gfi
address issu portfolio manag mine life extens errat
execut south deep remain key invest consider
gold field continu sell south african exposur view
posit importantli compani look beyond portfolio brownfield option
look toward futur build next gener mine begin
gruyer joint ventur australia road salar nort chile
gold field also enter joint ventur asanko akg-tsx
cover andrew breichmana asset ghana ad gold field exist africa
despit see posit momentum reposit futur
advoc wait-and-se approach gold field given august admiss
south deep mine requir signific restructur profit ensu
strike action underscor risk even temper long-term outlook
south deep mine repres outsiz portion gold field
rate share gold field under-perform rate target price
base equal weight price cash flow
consist three-year averag trade multipl base one-year
pleas see report initi anglogold gold field newcrest gold
univers detail
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
rate share gfi under-perform posit
momentum reposit futur
outweigh errat execut south deep
gfi trade npv estim bmo metal
price assumpt vs larg produc averag
target price reflect cfp
upsid scenario base
cfp bmo metal price assumpt
downsid scenario base
cfp bmo metal price assumpt
usd
resolut labour issu restructur south deep
gold field global larg gold mine compani
oper australia ghana peru south africa
bottom line believ obseva provid compel case nolasiban
ivf opportun day potenti file europ among
largest ivf market expect share reflect greater nolasiban valu
commerci approach visibl peak sale opportun
expect uf phase data valid linzagolix favor profil market
leader orilissa enabl drug captur meaning share despit third
gnrh antagonist reach market ptl remain upsid estim
nolasiban opportun remain underappreci obseva highlight larg
grow global vitro fertil ivf market cycl annual
europ exhibit believ investor hesit assign valu nolasiban
given uncertainti broad adopt due lack standard practic guidelin
howev see opportun nolasiban implant phase studi provid
optim protocol improv ivf birth rate
expect patient pay nolasiban kol panelist day
agreement reason price point signific proport patient
would like opt better chanc success nolasiban treatment exampl
preimplant genet diagnosi pgd option procedur cost
addit europ pgd reimburs yet patient elect
test similarli pgd grown ivf procedur
despit evid pgd improv pregnanc birth rate
larg market support linzagolix opportun believ obsv trade discount
competitor myov linzagolix trail myovant relugolix clinic develop
like third gnrh antagonist market orilissa elagolix
relugolix one- three-year lead endometriosi linzagolix
one year behind uterin fibroid uf addit believ endometriosi
uf market larg enough support three gnrh antagonist given million
diagnos endometriosi patient plu million undiagnos million
low-dos option without add-back therapi off-set late market entri
enabl achiev risk-adjust peak world-wide sale
believ obseva best drug
profil among gnrh antagonist enabl take
meaning market share uterin fibrosi
pipelin drug nolasiban ivf
total liabil share equiti
target price base dcf analysi free cash
flow discount rate
assum nolasiban improv ivf live birth rate
posit phase data pre-term labor
believ posit nolasiban data would
rais probabl success increas risk-
revenu model
assum nolasiban show increas
live birth rate without benefit live birth rate
nolasiban develop could discontinu
usd
phase interim data late phase
obseva provid therapeut treatment increas
address condit compromis health anywher
pregnanc concept birth primari
lead indic uterin fibroid endometriosi ivf-
upgrad outperform market perform
bottom line public outlook upgrad share
outperform market perform transit sleep apnea
compani one full interconnect throw benefit recent acquisit
new product launch good year stock specif
year integr matrixcar propel health one launch mobi copd
devic opportun addit oper leverag increas
estim target price
transit respiratori product compani one full
interconnect start core sleep apnea franchis flagship airfit
airfit airtouch mask far end product cycl yet
manag continu innov launch quietair technolog april
airfit mask octob outsid sleep apnea highli
anticip mobi portabl oxygen concentr poc final launch
product somewhat behind close door chronic obstruct
pulmonari disord copd market remain real opportun affect
connect care data analyt simpl verbiag manag
help compani drive deeper market penetr better adher rate
turn increas mask resuppli interconnect effort bulk
well beyond brightre acquisit healthcarefirst may
matrixcar novemb acquisit acquisit expand softwar
connect durabl medic equip dme channel hospic care
skill nurs senior live vertic
regard expens wit final leverag restructur vertic
sleep respiratori software-as-a-servic allow better expens manag
model oper margin expand y/i includ
matrixcar propel health model increas revenu
billion organ billion ep
revenu billion billion ep
revenu billion billion
ep higher estim increas target
base ep rang
leverag respiratori devic provid
cloud-connect medic data solut patient
physician
good sold
sale
 sale
chang incl fx impact
target price base ep
success abl integr recent
acquisit respiratori sleep apnea copd
busi cloud system
integr sleep apnea copd busi cost
expect
usd
resm benefit full launch mobi
poc devic continu adopt airfit
mask
leader obstruct sleep-disord
market includ obstruct sleep apnea osa
respiratori disord occur sleep
upgrad outperform detail sum-of-the-part
epsilon support upsid
bottom line upgrad share outperform market perform
leav price target believ strateg acquir valu epsilon
highli public market current support breakdown
valuat epsilon seven unit separ share current sit near three-
year low transact could announc within next month valu
epsilon ev/adjust ebitda could see sold whole
seven compon epsilon base manag commentari
earn call confer earn slide deck well prior
coverag convers compon estim valu follow
convers estim gener adjust ebitda
appli multipl arriv valu believ convers
larg compos old dotomi busi acquir valueclick
renam later convers later acquir
platform estim gener adjust ebitda
appli multipl arriv valu believ platform
busi would includ consum market databas loyalti market
program well agil harmoni digit messag platform
auto offer estim gener adjust ebitda
appli multipl arriv valu
cj affili estim gener adjust ebitda
appli multipl arriv valu
data estim gener adjust ebitda appli
multipl arriv valu believ data busi would
includ abacu shopper voic total sourc
epsilon agenc estim gener adjust ebitda
appli multipl arriv valu
convers agenc estim gener adjust ebitda
appli multipl arriv valu
valuat price target remain base sum-of-the-part valuat
believ share properli reflect valu
could unlock potenti transact
low despit belief transact could
announc within next month
total liabil share equiti
target price base sum-of-the-part
valuat appli price-to-earnings multipl card servic
ev/adjust ebitda multipl loyaltyon blend
ev/adjust ebitda multipl epsilon whole
ev/adjust ebitda multipl corpor
net core ep
multipl out-performance could
driven strong growth receiv lower-than-
expect charge-off strong growth brandloyalti
driven greater-than-expect new client win
compani sell epsilon attract valuat
multipl under-perform could
driven dramat deceler receiv growth
increas charge-off gross yield compress
increas competit brandloyalti compani
find buyer epsilon
usd
updat strateg review process could
come within next month compani card
servic perform updat releas mid-way
month earn januari
expect receiv guidanc
diversifi market credit
card compani compani oper three segment
epsilon full-servic direct market agenc includ
convers loyaltyon coalit canadian loyalti
program includ brandloyalti card servic
serv specialti retail victoria secret
amazon canadian tire stand
bottom line alway believ amazon present challeng
canadian tire point futur recent commiss market
research survey canadian order gather addit data
consum usag amazon canada impact amazon
histor found canadian tire retail busi tend trade
valuat discount rel major consum stock larg due investor
concern amazon rate outperform salmon bmo capit market
present immin threat fulli build categori compet
canadian tire howev believ lower valuat valid
canadian tire continu report posit comp grow oper profit
recent commiss market research survey canadian order
gather addit data consum usag amazon canada
believ three key takeaway survey
prime membership canada increas significantli last year
base survey one year ago found prime penetr
current survey suggest prime membership penetr
fresh/frozen groceri appear drive prime membership canada
previous hypothes key amazon gain prime member canada
would develop fresh/frozen groceri offer howev amazon
abl significantli increas prime penetr last twelv month
despit centre-of-store/pantri groceri offer
consum significantli prefer amazon ca offer canadian tire on-line
offer howev canadian tire continu report strong comp despit
amazon grow prime membership increas presenc canada
overal believ survey suggest amazon presenc rapidli
becom domin canada howev canadian tire appear
mitig impact amazon busi uniqu product offer
hous brand high/low merchandis techniqu data loyalti platform
conveni store locat result believ canadian tire continu
experi growth within current brick mortar presenc continu
rate canadian tire outperform
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
canadian tire continu gener oper
leverag improv merchandis effort
control cost across retail banner
valu canadian tire basi
higher-than-expect compstore improv merchandis
strategi stronger oper leverag could result
organ retail ebitda growth appli multipl
lower-than-expect compstore deterior oper
margin could lead declin retail ebitda
appli multipl retail ebitda would impli
cad
given sustain improv ctc result
believ current multipl accur reflect
valu canadian tire core busi consist strong
futur quarterli earn result drive momentum
potenti rais canadian tire retail valuat
canadian tire corpor ctc one canada largest
retail canadian tire banner store
across canada sell product categori
automot applianc decor hardwar tool
leisur sport good ctc also addit retail
banner retail petroleum sale interest
reit financi servic
defens flow trend remain intact care stapl display bullish creation breakout
etf aum volum increas believ valuabl sourc evalu investor posit provid -list
sentiment analysi aid select canadian-list exposur
sentiment gaug high yield sr loan market turn sharpli bearish januari recent sell-off
consist investor sentiment group suffer billion outflow recent price weak
trigger second leg outflow exhibit summer weve repeatedli highlight equiti market defens
rotat present defens flow trend remain intact
lead oct sell-off health care etf experienc billion inflow sinc group attract
anoth million asset form inflow break-out pattern exhibit
inflow stapl etf surg group rose two-year high exhibit
canada note consist outflow multipl cdn-list high yield etf investor sold long durat
reposit cash purpos high interest save etf share outstand doubl august level attract
million asset see fix incom flow report
speak bmo cm salesperson subscrib sentiment updat
observ dispers member return within cdn-list dividend etf investor begin avoid dividend grower
favour qualiti high-dividend payer
summer investor sold em bought small-cap dividend stock push dividend
etf top momentum screener
oct equiti sell-off dividend etf one group experienc strong inflowsa
behaviour that consist inform ratio screen sinc growth optim fade sharpli industri
acceler outflow investor begin avoid dividend grower favour qualiti high-dividend payer updat
 exposur screen found ishar us high dividend equiti index etf xhd top list vanguard
dividend appreci index etf vgh fell sixth place exhibit
factor analysi also consist etf screen analysi show investor adjust post-q
environ underpin invest decis qualiti debt servic metric sinc compani
good debt servic abil outperform exhibit
report prepar analyst employ bmo nesbitt burn inc regist research analyst finra rule
disclosur statement includ analyst certif pleas refer page
